Pharmafile Logo
Pharmafocus logo
Advanced Search
Eric Low

Open access research partnership to ‘crowdsource’ new myeloma drugs

January 27, 2016
Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …

News
alcon_ceo_mike_ball

Former Hospira boss joins Alcon as Novartis makes senior leadership changes

January 27, 2016
Novartis

Swiss firm Novartis has announced several leadership changes, effective February 1, 2016.In a briefing to present the company’s financial results, …

Appointment
merck_vib_m_org_1_rbvyvm_4c-01

New biopharma heads for Merck in North America and China

January 27, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck

Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …

Appointment
ian_bullock

Royal College of Physicians appoints new chief executive

January 27, 2016
Medical Communications Ian Bullock, Royal College of Physicians

Ian Bullock has been appointed chief executive of the Royal College of Physicians.  Prior to his appointment to the interim …

Appointment

PCI Pharma Services’ Tredegar site celebrates five years accident free

January 27, 2016
Medical Communications PCI Pharma Services

Pharmaceutical outsourcing suppler PCI Pharma Services has reached yet another significant safety milestone this month having operated for five full …

News
Press release

Is bioscience still getting lost in translation?

January 27, 2016
Research and Development CASMI, Centre for Sustainable Medical Innovation, Professor Richard Barker, R&D, bioscience

After several years of anguish about pharmaceutical pipelines, R&D productivity seems to be picking up.New medicines and cell and gene …

Feature

Pharma ‘forced to innovate in patient recruitment and retention’

January 27, 2016
Research and Development Tufts, clinical trials, patient recruitment, patient retention

The ‘critical need’ to improve recruitment and retention in clinical trials is driving pharma to create a “structural change in …

News
Jardiance

FDA reviews Jardiance as cardiovascular diabetes treatment

January 27, 2016
Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance

The FDA has accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for their diabetes drug Jardiance to be …

News
karim_husny

Alliance Pharmaceuticals appoints new head of international business

January 27, 2016
Medical Communications, Sales and Marketing Alliance Pharmaceuticals

Alliance Pharmaceuticals has appointed Karim Husny as head of international business- a role in which he will support all Alliance …

Appointment
NHS NICE logo

NICE recommends six drugs in final guidance

January 27, 2016
Research and Development, Sales and Marketing NHS, NICE

NICE has published final recommendations approving drug treatments for ovarian cancer, prostate cancer, multiple myeloma, gastric cancer and idiopathic pulmonary …

News

Johnson & Johnson hit by fall in 2015 sales

January 27, 2016
Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales

Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …

News

NICE backs biosimilars with arthritis drug endorsements

January 27, 2016
Research and Development, Sales and Marketing DMARDs, NICE, biosimilars, rheumatoid arthritis

NICE has published updated final guidance recommending seven biological disease modifying drugs (DMARDs) for treatment of severe rheumatoid arthritis which …

News
Amgen image

FDA to review Amgen’s Humira biosimilar

January 26, 2016
Manufacturing and Production ABP-501, Amgen, FDA, biosimilar

The FDA has accepted for review Amgen’s Biologics License Application (BLA) for ABP 501, a biosimilar candidate to AbbVie’s Humira …

News
Middle east

Post-sanctions Iran attracts pharma investment

January 26, 2016
Manufacturing and Production, Sales and Marketing Gulf Co-operation Council, Iran, Isral, Saudi Arabia, United Arab Emirates, middle east

Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to …

Feature
Mosquito image

GSK and Sanofi considering developing Zika vaccine

January 26, 2016
Manufacturing and Production GSK, Sanofi, World Health Organisation, Zika virus, microcephaly

Pharma companies Sanofi and GSK are reviewing the possibility of using their respective inoculation technologies to develop a vaccine for …

News
pharmacy Senegal

UK Government commits £1 billion to malaria fight

January 26, 2016
Manufacturing and Production Bill Gates, Chancellor, George Osborne, Ross Fund, infectious diseases, malaria

Chancellor George Osborne has set out details of a billion pound fund to develop, test and produce new products to …

News
shire_image

Shire tries again with lifitegrast dry eye FDA application

January 25, 2016
Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye disease, lifitegrast

Shire has resubmitted its New Drug Application (NDA) to the US FDA for its rejected dry eye syndrome drug lifitegrast. …

News
philippe_cotrel

Avacta appoints Philippe Cotrel as chief commercial officer

January 25, 2016
Manufacturing and Production, Research and Development Avacta

Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …

Appointment
matthewpfeffer_sm

New chief exec at MannKind

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …

Appointment

AbbVie VP joins UCB Pharma

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Pascale Richetta, UCB, UCB Pharma

Pascale Richetta will join the UCB as its new head of the bone therapy patient value unit as from February …

Appointment
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026